Back to Agenda
S17 : Field-Based Reconsideration of Protocol Design
Session Chair(s)
Toshiko Ishibashi, PhD, RN
Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan
Reconsideration of Protocol Design from Patient and Site perspectives
Speaker(s)
Kenneth Getz, MBA
Center For the Study of Drug Development, United States
Tufts Center for the Study of Drug Development
Sponsor Perspectives ~Stakeholder Involvement in Protocol Development~
Ryoichi Tanaka
Daiichi Sankyo Co., Ltd., Japan
Investigator Perspectives ~Own Experiences and Initiatives at Various Academic Societies~
Jiichiro Sasaki
Kitasato University School of Medicine, Japan
Professor, Research and Development Center for New Medical Frontiers
Naomi Sakurai
CSR-Project, NPO, Japan
President
Have an account?